World’s 1st company to have 2 Drug Eluting Stent technologies
with 10 years clinical safety and efficacy data
LEADING WITH VISION
EluNIR-PERL is Medinol’s most recent advancement in coronary DES. This seventh-generation stent utilizes a distinctive CoCr design composed of alternating struts widths and integrated radiopaque markers.
Furthermore, the delivery system features a specialized radiopaque metal spring tip designed for navigating through complex anatomies. These design elements are intended to equip physicians with precise positional information, facilitating accurate stent placement during PCI procedures.
Future Beyond Polymers with 10 Years of Safety
and Efficacy Data (ISAR TEST-5)
10-Year Proven Polymer-Free Stent
Backed by ISAR TEST-5, this cobalt chromium stent delivers Sirolimus via a polymer-free matrix of Probucol and Shellac Resin, ensuring safe, controlled release and enhanced healing. PEARL surface and abluminal coating boost drug delivery.
Heal with Polymer Free Technology
Everolimus Eluting Polymer Free stent, offering a unique combination of Probucol and Everolimus. Transever registry supports the safety and efficacy of the ISAR SUMMIT in 1000 patients.
Redefining Flexibility in Coronary Stents
10-Year Proven Polymer-Free Stent
Clinically backed by ISAR TEST-5, this cobalt chromium stent uses Sirolimus with Probucol and Shellac Resin—ensuring safe, controlled drug release and faster healing. PEARL surface and abluminal coating enhance delivery.
New generation DES providing synergy
CE-approved Sirolimus-eluting coronary stent built on a microporous stainless-steel platform with a biodegradable polymer. It boasts 10 years of RCT data from the ISAR TEST-4, demonstrating its safety and efficacy compared to the Xience stent. Additionally, it is recommended by the ESC 2018 guidelines.
Ultimate Trackability for Treating Complexity
CE-approved Sirolimus-Eluting Biodegradable Polymer Coronary Stent features a Cobalt Chromium platform, and a Stent Delivery System designed for balanced performance, making it suitable for use across all types of vessel anatomies. Backed by 10 years of clinical data, it demonstrates proven safety and efficacy.
